A medtech device designed to improve treatment for stroke patients has earned Galway’s Neuravi €19 million in Series B funding.
The round was led by European private equity firm Life Sciences Partners (LSP), and will allow Neuravi to commercialise its Embotrap device in European and US markets.
A thrombectomy device, Embotrap can be used to remove the blood clots that cause ischemic strokes, and restore blood flow to the brain quickly and simply.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team